Bolus nitroglycerine administration may havea place in CPR protocols, which needs to be evaluated in further clinical studies.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:We present a 75-year-old male patient having aortic stenosis for which transcatheter aortic valve implantation (TAVI)had been planned.
📊
Key Findings & Data:Cardiopulmonary resuscitation (CPR) followed by 10mg intravenous bolus nitroglycerine administration at the 40 min was per-formed.
💡
Conclusion & Impact:Bolus nitroglycerine administration may havea place in CPR protocols, which needs to be evaluated in further clinical studies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
We present a 75-year-old male patient having aortic stenosis for which transcatheter aortic valve implantation (TAVI)had been planned. Patient developed cardiac arrest before TAVI. Cardiopulmonary resuscitation (CPR) followed by 10mg intravenous bolus nitroglycerine administration at the 40 min was per-formed. Patient was conscious and cooperatedat the 80th hour following CPR and was stable hemodynamically. TAVI was applied on the 8th day and patient wasdischarged to home from the cardiology clinic on the 6th day after TAVI. Bolus nitroglycerine administration may havea place in CPR protocols, which needs to be evaluated in further clinical studies.
🔖
Cite This Article
ZUNGUR, M. (2022). Nitroglycerin in Cardiac Arrest Before Transcatheter Aortic Valve Implantation. Eurasian Journal of Medical Investigation, Cilt: 3 - Sayı: 1, 81–83. https://ajindex.com/articles/508711
Thaden JJ, Nkomo VT, Enriquez-Sarano M. The global burden of aortic stenosis. Prog Cardiovasc Dis 2014;56:565–71
Horne A Jr, Reineck EA, Hasan RK, Resar JR, Chacko M. Transcatheter aortic valve replacement: historical perspectives, current evidence, and future directions. Am Heart J 2014;168:414–23
Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis 2012;105:1461–52
Levy PD, Laribi S, Mebazaa A. Vasodilators in acute heart failure: review of the latest studies. Curr Emerg Hosp Med Rep 2014;2:126–32
Münzel T, Steven S, Daiber A. Organic nitrates: update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction. Vascul Pharmacol 2014;63:105–13
Ward WG, Reid RL. High-dose intravenous nitroglycerin during cardiopulmonary resuscitation for refractory cardiac arrest. Am J Cardiol 1984;53:17–25
Guglina ME. Intravenous jet administration of nitroglycerin in cardiogenic shock. Klin Med (Mosk) 1990;68:56–8
Guglina ME. High-dose nitroglycerin in cardiogenic shock. Klin Med [Mosk] 1997;75:27–30
Lurie KG, Voelckel WG, Iskos DN, et al. Combination drug therapy with vasopressin, adrenaline (epinephrine) and nitroglycerin improves vital organ blood flow in a porcine model of ventricular fibrillation. Resuscitation 2002;54:187–94
Franciosa JA, Limas CJ, Guiha NH, Rodriguera E, Cohn JN. Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet 1972;1:650–4
Stevenson LW, Bellil D, Grover-McKay M, Brunken RC, Schwaiger M, Tillisch JH, Schelbert HR. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987;60:654–8
Guiha NH, Cohn JN, Mikulic E, Franciosa JA, Limas CJ. Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med 1974;291:587–92
Chatterjee K, Swan HJ, Kaushik VS, Jobin G, Magnusson P, Forrester JS. Effects of vasodilator therapy for severe pump failure in acute myocardial infarction on short-term and late prognosis. Circulation 1976;53:797–802
Bayley S, Valentine H, Bennett ED. The haemodynamic responses to incremental doses of intravenous nitroglycerin in left ventricular failure. Intensive Care Med 1984;10:139–45
Frenneaux M, Williams L. Ventricular-arterial and ventricularventricular in